These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9208647)

  • 1. [Effect of thyrotropin-releasing hormone analogue (YM14673) on experimental brain contusion and edema in rats].
    Zhang JJ; Zhang SD
    Yao Xue Xue Bao; 1996; 31(4):250-3. PubMed ID: 9208647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel TRH analog, YM14673, stimulates intracellular signaling systems in the brain more potently than predicted by its pituitary actions.
    Mori M; Iriuchijima T; Yamada M; Murakami M; Kobayashi S
    Res Commun Chem Pathol Pharmacol; 1991 Jan; 71(1):17-26. PubMed ID: 1673800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of YM-14673, a new TRH analogue, on responses to morphine in rodents.
    Yamamoto M; Shimizu M; Ozawa Y
    Arch Int Pharmacodyn Ther; 1989; 300():29-36. PubMed ID: 2515820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel analog of TRH, YM14673, causes a decrease in brain TRH receptors in vitro.
    Monden T; Mizuma H; Yamada M; Murakami M; Mori M
    Endocr Res; 1995 Nov; 21(4):803-14. PubMed ID: 8582330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
    Shimizu M; Yamamoto M; Kobayashi M
    Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of YM-14673, a new TRH analogue, on behavioral and electrophysiological changes in rats subjected to electrical lesion of the internal capsule.
    Yamamoto M; Shimizu-Sasamata M; Kawabata S; Terai M
    Arch Int Pharmacodyn Ther; 1990; 306():5-17. PubMed ID: 2127525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective.
    Roof RL; Duvdevani R; Heyburn JW; Stein DG
    Exp Neurol; 1996 Apr; 138(2):246-51. PubMed ID: 8620923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
    Matsui K; Wada K; Kwak S
    Eur J Pharmacol; 1994 Mar; 254(3):295-7. PubMed ID: 8013566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ifenprodil, a polyamine site NMDA receptor antagonist, on brain edema formation following asphyxial cardiac arrest in rats.
    Xiao F; Pardue S; Arnold T; Carden D; Alexander JS; Monroe J; Sharp CD; Turnage R; Conrad S
    Resuscitation; 2004 May; 61(2):209-19. PubMed ID: 15135198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia.
    Yamamoto M; Shimizu M; Okamiya H
    Eur J Pharmacol; 1990 Jun; 181(3):207-14. PubMed ID: 2116971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new thyrotropin-releasing hormone analogue administered in rats 1 week after middle cerebral artery occlusion.
    Yamamoto M; Tamura A; Kirino T; Hirakawa M; Shimizu M; Sano K
    Stroke; 1989 Aug; 20(8):1089-91. PubMed ID: 2756541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats.
    Yamamoto M; Tamura A; Kirino T; Shimizu-Sasamata M; Sano K
    Eur J Pharmacol; 1991 May; 197(2-3):117-23. PubMed ID: 1915564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of single and combination drug treatment strategies in experimental brain trauma.
    Faden AI
    J Neurotrauma; 1993; 10(2):91-100. PubMed ID: 8411221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
    Yamamoto M; Ozawa Y; Takeuchi H
    Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective action of thyroliberin and its synthetic analog (PR-546) in craniocerebral trauma].
    Gurskaia IE; Pleukhova OA; Beliakov NA; Kuz'michev SA; Servatinskiĭ GL; Romanovskiĭ PIa
    Biull Eksp Biol Med; 1990 May; 109(5):432-4. PubMed ID: 2116194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of glucose-6-phosphate polyclonal antibody on vasogenic brain edema in rats].
    Tao Z; Lu BX; Zhang YZ; Cheng G
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1041-3. PubMed ID: 16864109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance learning in senescence-accelerated mice.
    Yamamoto M; Iwai A; Ozawa Y
    Pharmacol Biochem Behav; 1990 Mar; 35(3):727-9. PubMed ID: 2111030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats.
    Okada M
    J Neurochem; 1991 May; 56(5):1544-7. PubMed ID: 1901593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.